Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Efficacy of Artesunate for Treatment of Cytomegalovirus Reactivations in Allogeneic Haematopoietic Stem Cell Transplant Recipients Who Are Intolerant/Unsuitable for Ganciclovir Therapy

Ramnath K Shenoy, MD, Anant Gokarn, MD, Anup Toshniwal, MDDM, Siddhesh Arun Kalantri, MD, Akanksha Chichra, DNB, Sachin Punatar, MBBS,MDDM MDcal Oncology, Avinash Bonda, MD DM, Lingaraj Nayak, MDDM MDcal Oncology, Libin J Mathew, Vivek Bhat, MD, Sanjay Biswas, MD, Rohini Kelkar, MD, Navin Khattry, MD DM MDcal Oncology

Blood (2019) 134 (Supplement_1): 4506.

https://doi.org/10.1182/blood-2019-128766

Published: 2019

Journal Articles

The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation

Guo-Pan Yu, MD, Zhao Yin, Zhiping Fan, Fen Huang, Na Xu, Ling Jiang, Zhixiang Wang, PhD, Li Xuan, MD, Qifa Liu, MD, Ru Feng, MD, Jing Sun

Blood (2019) 134 (Supplement_1): 5659.

https://doi.org/10.1182/blood-2019-126705

Published: 2019

Journal Articles

Risk Factors of BK Virus Cystitis in Haematopoietic Stem Cell Transplantation-a Retrospective Monocentric Study

Eléonore Kaphan, Raphaele Germi, Martin Carre, Claude-Eric Bulabois, MD, Sebastien Bailly, Jean-Yves Cahn, MD, Anne Thiebaut-Bertrand

Blood (2018) 132 (Supplement 1): 3361.

https://doi.org/10.1182/blood-2018-99-115321

Published: 2018

Journal Articles

Successful Management of Progressive Multifocal Leukoencephalopathy Post TCR Alphabeta/CD19 Depleted Haploidentical Stem Cell Transplant

Satya Prakash Yadav, MBBS, MD, Shruti Kohli, MD, Sagar Nivargi, Dhwanee Thakkar, Neha Rastogi

Blood (2018) 132 (Supplement 1): 5699.

https://doi.org/10.1182/blood-2018-99-119042

Published: 2018

Journal Articles

Intravesicular Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis (BKV-HC) Following Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Graham Tooker, Ashraf Z. Badros, MD, Jennifer Nishioka, PharmD, David Riedel, MD

Blood (2018) 132 (Supplement 1): 2085.

https://doi.org/10.1182/blood-2018-99-110887

Published: 2018

Journal Articles

BK Virus Induced Haemorrhagic Cystitis in Haematopoietic Stem Cell Transplant Setting — a 10 Year Retrospective Case Control Study

Asha Mary Abraham, MBBS, MD PhD, Sharon Lionel, Anu Korula, MBBS, MD DM, Anup Devasia, Nisham PN, Kulkarni Uday Prakash, Kavitha M Lakshmi, MSc, Aby Abraham, MD DM, Alok Srivastava, MD, Vikram Mathews, MD DM, Biju George, MDDM

Blood (2017) 130 (Supplement 1): 5470.

https://doi.org/10.1182/blood.V130.Suppl_1.5470.5470

Published: 2017

Journal Articles

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Eric Anthony Coomes, MD, Amanda Jacques, BScPharm, RPh, ACPR, Fotios V. Michelis, MD PhD, Dennis (Dong-Hwong) Kim, MD PhD, Santhosh Thyagu, MD, Auro Viswabandya, MDMDcine,DM Clinical Hematology, Jeff H. Lipton, MD PhD, Hans A. Messner, MD PhD, Uday Deotare, MD

Blood (2017) 130 (Supplement 1): 5479.

https://doi.org/10.1182/blood.V130.Suppl_1.5479.5479

Published: 2017

Journal Articles

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Anant Gokarn, MD, Anup Toshniwal, MD, Amogh Pathak, MBBS, Sankalp Arora, MBBS, Avinash Bonda, MD DM, Pankaj Dwivedi, MD, Sachin Punatar, MD DM, Vivek Bhat, MD, Sanjay Biswas, MD, Rohini Kelkar, MD, Tapan Saikia, MD, Sadhana Kannan, MSc, Navin Khattry, MD DM

Blood (2017) 130 (Supplement 1): 1945.

https://doi.org/10.1182/blood.V130.Suppl_1.1945.1945

Published: 2017

Journal Articles

Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant

Prashant Hiwarkar, Persis Amrolia, Ponni Sivaprakasam, Su Han Lum, Hemalatha Doss, Ciara O’Rafferty, Toni Petterson, Katharine Patrick, Juliana Silva, Mary Slatter, Sarah Lawson, Kanchan Rao, Colin Steward, Adam Gassas, Paul Veys, Robert Wynn

Blood (2017) 129 (14): 2033–2037.

https://doi.org/10.1182/blood-2016-11-749721

Published: 2017

Includes: Supplemental data

Journal Articles

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients

Firas El Chaer, Dimpy P. Shah, Roy F. Chemaly

Blood (2016) 128 (23): 2624–2636.

https://doi.org/10.1182/blood-2016-06-688432

Published: 2016

Journal Articles

Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant

Susan Prockop, MD, Ekaterina Doubrovina, MD PhD, Aisha N Hasan, MD, Parastoo B Dahi, MD, Sergio Giralt, MD, Guenther Koehne, MD PhD, Nancy A. Kernan, MD, Esperanza B Papadopoulos, MD, Rachel Lehrman, Irene Rodriguez-Sanchez, Richard J. O'Reilly, MD

Blood (2016) 128 (22): 61.

https://doi.org/10.1182/blood.V128.22.61.61

Published: 2016

Journal Articles

Clinical Efficacy of BK Virus Specific T-Cells in Treatment of Severe Refractory Hemorrhagic Cystitis after HLA Haploidentical Transplantation

Oscar M. Pello, Anne Bradshaw, Andrew Innes, Sally-Anne Finn, Emma Bray, Shab Uddin, Eduardo Olavarria, Jane F. Apperley, MD, Jiří Pavlů

Blood (2016) 128 (22): 5726.

https://doi.org/10.1182/blood.V128.22.5726.5726

Published: 2016

Journal Articles

Efficacy of Third Party BK Virus (BKV) Specific Cytotoxic T-Lymphocytes Generated By Ex Vivo Expansion for the Treatment of BKV Infection in Stem Cell Transplant Recipients, a Phase 2 Trial

Blood (2016) 128 (22): 504.

https://doi.org/10.1182/blood.V128.22.504.504

Published: 2016

Journal Articles

Hemorrhagic Cystitis in Haploidentical Hematopoietic STEM CELL Trasplant: Retrospective Study and Comparison with a NON-Haploidentical DONOR Transplant Group

Nerea Arratibel, Monica Cabrero, Estefania Perez, Oriana Lopez, Lucia Lopez, Ana A. Martin, Alvaro Veiga, Monica Baile, Veronica Gonzalez, Felix Lopez, Oscar Ferre, Luis García, Dolores Caballero, MD PhD, Lourdes Vazquez, MD, Maria-Victoria Mateos, MD PhD

Blood (2016) 128 (22): 3418.

https://doi.org/10.1182/blood.V128.22.3418.3418

Published: 2016

Journal Articles

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Brandon M. Triplett, MD, Bradley Muller, Guolian Kang, PhD, Shane J Cross, PharmD, Joseph Moen, Mari H Dallas, MD, Christine Hartford, MD, William E. Janssen, PhD, Ping Law, PhD, Ewelina K. Mamcarz, MD, David R Shook, MD, Ashok Srinivasan, MD, Randall T Hayden, MD, Wing Leung, MD PhD

Blood (2015) 126 (23): 624.

https://doi.org/10.1182/blood.V126.23.624.624

Published: 2015

Journal Articles

Cidofovir Treatmenf For Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation For High Risk Hematological Malignancies

Lara Crucitti, MD, Matteo Carrabba, MD, Sarah Marktel, MD, Andrea Assanelli, MD, Andrea Salonia, MD, Raffaella Greco, MD, Luca Vago, MD, PhD, Francesca Lorentino, MD, Maria Teresa Lupo Stanghellini, MD, Massimo Bernardi, MD, Consuelo Corti, MD, Jacopo Peccatori, MD, Fabio Ciceri, MD

Blood (2013) 122 (21): 4557.

https://doi.org/10.1182/blood.V122.21.4557.4557

Published: 2013

Journal Articles

The Effectiveness Of Cidofovir In Disseminated Adenovirus Infections After Pediatric HSCT Is Closely Related To Lymphocyte Reconstitution

Gertjan Lugthart, MD, Marloes A. Oomen, BSc, Cornelia M. Jol-van der Zijde, Lynne M. Ball, FRCP, FRCPath, MD, FRCPCH, Dorine Bresters, MD, PhD, Wouter J.W. Kollen, MD, PhD, Frans J. Smiers, MD, PhD, Clementien L. Vermont, MD, PhD, Robbert G.M. Bredius, MD, PhD, Marco W. Schilham, PhD, Maarten J.D. van Tol, PhD, Arjan C. Lankester, MD, PhD

Blood (2013) 122 (21): 3292.

https://doi.org/10.1182/blood.V122.21.3292.3292

Published: 2013

Journal Articles

Poor Graft Function in Recipients of T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplants (HSCT) Is Mostly Related to Viral Infections and Anti-Viral Therapy.

Roni Tamari, MD, Sheetal Ramnath, Deborah Kuk, MS, Craig S. Sauter, MD, Doris M Ponce, MD, Sean Devlin, PhD, James W. Young, MD, Sergio Giralt, MD, Hugo R Castro-Malaspina, MD

Blood (2012) 120 (21): 3147.

https://doi.org/10.1182/blood.V120.21.3147.3147

Published: 2012

Journal Articles

Cidofovir Is a Highly Effective and Safe Salvage Therapy in Ganciclovir Resistant Cytomegalovirus Reactivation Following Allogeneic Haematopoietic Stem Cell Transplantation

David Lewis, Francesca Farina, Sandeep Nagra, Sridhar Chaganti, Annette Pachnio, PhD, Jane Nunnick, Paul AH Moss, MD PhD, Ram Malladi, Charles F. Craddock, BM, MRCP, MRCPath

Blood (2012) 120 (21): 1923.

https://doi.org/10.1182/blood.V120.21.1923.1923

Published: 2012

Journal Articles

BK Virus Disease Following Allogeneic Stem Cell Transplantation: A Cohort Analysis

Nienke MG Rorije, Margaret M Shea, Gowri Satyanarayana, MD, Sarah P Hammond, MD, Vincent T Ho, MD, Lindsey R Baden, MD, Joseph H Antin, MD, Robert J Soiffer, MD, Francisco M Marty, MD

Blood (2012) 120 (21): 1927.

https://doi.org/10.1182/blood.V120.21.1927.1927

Published: 2012

NARROW

Efficacy of Artesunate for Treatment of Cytomegalovirus Reactivations in Allogeneic Haematopoietic Stem Cell Transplant Recipients Who Are Intolerant/Unsuitable for Ganciclovir Therapy

The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation

Risk Factors of BK Virus Cystitis in Haematopoietic Stem Cell Transplantation-a Retrospective Monocentric Study

Successful Management of Progressive Multifocal Leukoencephalopathy Post TCR Alphabeta/CD19 Depleted Haploidentical Stem Cell Transplant

Intravesicular Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis (BKV-HC) Following Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

BK Virus Induced Haemorrhagic Cystitis in Haematopoietic Stem Cell Transplant Setting — a 10 Year Retrospective Case Control Study

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients

Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant

Clinical Efficacy of BK Virus Specific T-Cells in Treatment of Severe Refractory Hemorrhagic Cystitis after HLA Haploidentical Transplantation

Efficacy of Third Party BK Virus (BKV) Specific Cytotoxic T-Lymphocytes Generated By Ex Vivo Expansion for the Treatment of BKV Infection in Stem Cell Transplant Recipients, a Phase 2 Trial

Hemorrhagic Cystitis in Haploidentical Hematopoietic STEM CELL Trasplant: Retrospective Study and Comparison with a NON-Haploidentical DONOR Transplant Group

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Cidofovir Treatmenf For Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation For High Risk Hematological Malignancies

The Effectiveness Of Cidofovir In Disseminated Adenovirus Infections After Pediatric HSCT Is Closely Related To Lymphocyte Reconstitution

Poor Graft Function in Recipients of T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplants (HSCT) Is Mostly Related to Viral Infections and Anti-Viral Therapy.

Cidofovir Is a Highly Effective and Safe Salvage Therapy in Ganciclovir Resistant Cytomegalovirus Reactivation Following Allogeneic Haematopoietic Stem Cell Transplantation

BK Virus Disease Following Allogeneic Stem Cell Transplantation: A Cohort Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only